SEC 13F Intelligence

Orbimed Advisors LLC / ESPR

Orbimed Advisors LLC’s Esperion Therapeutics Inc Ne Position

Does Orbimed Advisors LLC own Esperion Therapeutics Inc Ne (ESPR)? Yes — 10.57M shares worth $29M (+0.57% of its 13F portfolio) as of Q1 2026, up from 5.97M shares the prior filed quarter.

Position Value
$29M
Q1 2026
Shares
10.57M
% of Portfolio
+0.57%
Quarters Held
3
currently held

Position History ESPR

Reported value by quarter
Q1 ’24: $37MQ1 ’24Q4 ’25: $22MQ4 ’25Q1 ’26: $29MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202610.57M$29M+0.57%
Q4 20255.97M$22M+0.45%
Q1 202413.71M$37M+0.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of ESPR.